Skip to main content

Advertisement

Log in

The treatment of segmental bone defects in rabbit tibiae with vascular endothelial growth factor (VEGF)-loaded gelatin/hydroxyapatite “cryogel” scaffold

  • Original Article
  • Published:
European Journal of Orthopaedic Surgery & Traumatology Aims and scope Submit manuscript

Abstract

The aim of this study was to investigate the effectiveness of a novel hydroxyapatite containing gelatin scaffold—with and without local vascular endothelial growth factor (VEGF) administration—as the synthetic graft material in treatment of critical-sized bone defects. An experimental nonunion model was established by creating critical-sized (10 mm. in length) bone defects in the proximal tibiae of 30 skeletally mature New Zealand white rabbits. Following tibial intramedullary fixation, the rabbits were grouped into three: The defects were left empty in the first (control) group, the defects were grafted with synthetic scaffolds in the second group, and synthetic scaffolds loaded with VEGF were administered at bone defects in the third group. Five rabbits in each group were killed on 6th and 12th weeks, and new bone growth was assessed radiologically, histologically and with dual-energy X-ray absorptiometry (DEXA). At 6 weeks, VEGF-administered group had significantly better scores than the other two groups. The second group also had significantly better scores than the control group. At 12 weeks, while no significant difference was noted between the second and third groups, these two groups both had significantly better scores in all criteria compared with the control group. There were no signs of complete fracture healing in the control group. The administration of hydroxyapatite containing gelatin scaffold yielded favorable results in grafting the critical-sized bone defects in this experimental model. The local administration of VEGF on the graft had a positive effect in the early phase of fracture healing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Giannoudis PV, Dinopoulos H, Tsiridis E (2005) Bone substitutes: an update. Injury 36S(3):20–27

    Article  Google Scholar 

  2. Roberts SJ, Howard D, Buttery LD, Shakesheff KM (2008) Clinical applications of musculoskeletal tissue engineering. Br Med Bull 86:7–22

    Article  PubMed  CAS  Google Scholar 

  3. Bolgen N, Plieva F, Galaev IY, Mattiasson B, Piskin E (2007) “Cryogelation” for preparation of novel biodegradable tissue engineering scaffolds. J Biomater Sci Polymer Ed 18(9):1165–1179

    Article  CAS  Google Scholar 

  4. Glowacki J (1998) Angiogenesis in fracture repair. Clin Orthop (355S):82–89

  5. Strydom DJ (1998) The angiogenins. Cell Mol Life Sci 54(8):811–824

    Article  PubMed  CAS  Google Scholar 

  6. Street J, Bao M, deGuzman L, Bunting S, Peale FV Jr, Ferrara N et al (2002) Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99(15):9656–9661

    Article  PubMed  CAS  Google Scholar 

  7. Eckardt H, Ding M, Lind M, Hansen ES, Christensen KS, Hvid I (2005) Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion model. J Bone Joint Surg Br 87(10):1434–1438

    PubMed  CAS  Google Scholar 

  8. Maia J, Ferreira L, Carvalho R, Ramos MA, Gil MH (2005) Synthesis and characterization of new injectable and degradable dextran-based hydrogels. Polymer 46(23):9604–9614

    Article  CAS  Google Scholar 

  9. Inci I, Kirsebom H, Galaev IG, Mattiasson B, Piskin E (2012) Gelatin cryogels crosslinked with oxidized dextran and containing freshly formed hydroxyapatite as potential bone tissue engineering scaffolds. J Tissue Eng Regen Med. doi:10.1002/term1464 [Epub ahead of print]

  10. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC (1994) Recombinant human bone morphogenic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop (301):302–312

  11. Patel ZS, Young S, Tabata Y, Jansen JA, Wong ME, Mikos AG (2008) Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 43(5):931–940

    Article  PubMed  CAS  Google Scholar 

  12. Giannoudis PV, Einhorn TA, Marsh D (2007) Fracture healing: the diamond concept. Injury (38S):3–6

  13. Tsiridis E, Upadhyay N, Giannoudis P (2007) Molecular aspects of fracture healing: which are the important molecules? Injury (38S):11–25

  14. Keramaris NC, Calori GM, Nikolaou VS, Schemitsch EH, Giannoudis PV (2008) Fracture vascularity and bone healing: a systematic review of the role of VEGF. Injury (39S):45–57

  15. Beamer B, Hettrich C, Lane J (2009) Vascular endothelial growth factor: an essential component of angiogenesis and fracture healing. HSS J (9) [Epub ahead of print]

  16. Augustin G, Antabak A, Davila S (2007) The periosteum. Part 1: anatomy, histology and molecular biology. Injury 38(10):1115–1130

    Article  PubMed  Google Scholar 

  17. Gerber HP, Vu TH, Ryan AM (1999) VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5(6):623–628

    Article  PubMed  CAS  Google Scholar 

  18. Dimitriou R, Tsiridis E, Carr I, Simpson H, Giannoudis PV (2006) The role of inhibitory molecules in fracture healing. Injury (37S):20–29

  19. Kleinheinz J, Stratmann U, Joos U, Wiessman HP (2005) VEGF-activated angiogenesis during bone regeneration. J Oral Maxillofac Surg 63(9):1310–1316

    Article  PubMed  Google Scholar 

  20. Tripathi A, Kumar A (2011) Multi-featured macroporous agarose-alginate cryogel: synthesis and characterization for bioengineering applications. Macromol Biosci 11(1):22–35

    Article  PubMed  CAS  Google Scholar 

  21. Liu Y, Lu Y, Tian X, Cui G, Zhao Y, Yang Q et al (2009) Segmental bone regeneration using an rhBMP-2-loaded gelatin/nanohydroxyapatite/fibrin scaffold in a rabbit model. Biomaterials 30(31):6276–6285

    Article  PubMed  CAS  Google Scholar 

  22. Ichinohe N, Kuboki Y, Tabata Y (2008) Bone regeneration using titanium nonwoven fabrics combined with fgf-2 release from gelatin hydrogel microspheres in rabbit skull defects. Tissue Eng Part A 14(10):1663–1671

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This experimental research was performed in Gazi University Medical School, Animal Experiments Laboratory and was funded by Gazi University, Department of Scientific Research Projects with the project number SBE-1/2009/47.

Conflict of interest

No benefits in any form have been or will be received from a commercial party related directly or indirectly to the subject of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Burak Yagmur Ozturk.

Additional information

Disclaimer: We hereby state that all ethical, legal and animal rights wise considerations were fulfilled during and after this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ozturk, B.Y., Inci, I., Egri, S. et al. The treatment of segmental bone defects in rabbit tibiae with vascular endothelial growth factor (VEGF)-loaded gelatin/hydroxyapatite “cryogel” scaffold. Eur J Orthop Surg Traumatol 23, 767–774 (2013). https://doi.org/10.1007/s00590-012-1070-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00590-012-1070-4

Keywords

Navigation